PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'NHC Key Laboratory of Enteric Pathogenic Microbiology (Jiangsu Provincial Center for Disease Control and Prevention), Nanjing, Jiangsu 210009, China.\', \'Shenzhen Kangtai Biological Products Co., Ltd., Shenzhen, Guangdong 518057, China.\', \'NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.\', \'Beijing Minhai Biological Technology Co., Ltd., Beijing 102600, China.\', \'Huaiyin District Center for Disease Control and Prevention, Huai\'an, Jiangsu 223003, China.\', \'Vazyme Biotech Co., Ltd, Nanjing, Jiangsu 210000, China.\', \'National Institutes for Food and Drug Control, Beijing 102629, China.\', \'Center for Global Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/CM9.0000000000001573
?:doi
?:hasPublicationType
?:journal
  • Chinese medical journal
is ?:pmid of
?:pmid
?:pmid
  • 33928916
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.52
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33928916>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33928916>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all